Literature DB >> 15547398

Pleomorphic adenoma of the palate.

Luigi Clauser1, Stefano Mandrioli, Vittorio Dallera, Elisabetta Sarti, Manilio Galiè, Luigi Cavazzini.   

Abstract

Pleomorphic adenoma, is the most common tumor (50%) of the major and minor salivary glands. Seventy percent of the tumors of the minor salivary glands are pleomorphic adenomas, and the most common intraoral site is the palate, followed by the upper lip and buccal mucosa. Pleomorphic adenoma appears as a painless firm mass and, in most cases, does not cause ulceration of the overlying mucosa. Generally it is mobile, except when it occurs in the hard palate. Intraoral mixed tumors, especially those noted within the palate, lack a well-defined capsule. Lesions of the palate frequently involve periosteum or bone. Approximately 25% of benign mixed tumors undergo malignant transformation. Treatment for the pleomorphic adenoma is radical surgery. Inadequate resection leads to local recurrence. The authors report a palate pleomorphic adenoma in a 67-year-old female patient.

Entities:  

Mesh:

Year:  2004        PMID: 15547398     DOI: 10.1097/00001665-200411000-00029

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  4 in total

1.  Pleomorphic Adenoma of Upper Lip: A Rare Case Presentation.

Authors:  Jas Simran Singh Bhatia
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-11-15

2.  Pleomorphic adenoma of the palate.

Authors:  Subhas Chandra Debnath; A K Saikia; Antara Debnath
Journal:  J Maxillofac Oral Surg       Date:  2011-01-20

3.  Pleomorphic adenoma of hard palate: an experience.

Authors:  Suhail Amin Patigaroo; Fozia Amin Patigaroo; Junaid Ashraf; Nazia Mehfooz; Mohd Shakeel; Nazir A Khan; Masood H Kirmani
Journal:  J Maxillofac Oral Surg       Date:  2012-10-30

4.  Keratinizing pleomorphic adenoma: An unusual case report.

Authors:  Aanchal Tandon; Rohit Jaiswal; Safia Siddiqui; Bharadwaj Bordoloi
Journal:  J Oral Maxillofac Pathol       Date:  2018-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.